One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And … – MarketWatch (press release)
One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And …MarketWatch (press release)NATICK, Mass., May 15, 2012 /PRNewswire via COMTEX/ — Boston Scientific Corporation (NYSE:BSX) announces that the SYNERGY(TM) Everolimus-Eluting Bioabso…